- decreased leukocyte cell number / IMPC
- abnormal cornea morphology / IMPC
- corneal opacity / IMPC
- abnormal iris morphology / IMPC
- trunk curl / IMPC
- narrow eye opening / IMPC
- corneal vascularization / IMPC
- increased mean corpuscular hemoglobin / IMPC
- absent pinna reflex / IMPC
- decreased bone mineral content / IMPC
B6Brd;B6Dnk;B6N-Tyrc-Brd-Spns2tm1b(KOMP)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:08571 |
International strain name | B6Brd;B6Dnk;B6N-Tyrc-Brd-Spns2tm1b(KOMP)Wtsi/WtsiH |
Alternative name | EPD0090_5_B04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Spns2tm1b(KOMP)Wtsi |
Gene/Transgene symbol | Spns2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0090_5_B04. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using an X-linked CMV-Cre driver (EM:05414; C57BL/6N-Hprttm1(CMV-cre)Wtsi/WtsiOulu) for this purpose. Click here for more information on KOMP final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References |
|
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased bone mineral content / IMPC
- absent pinna reflex / IMPC
- corneal vascularization / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased leukocyte cell number / IMPC
- decreased circulating HDL cholesterol level / IMPC
- corneal opacity / IMPC
- decreased circulating glucose level / IMPC
- increased circulating creatine kinase level / IMPC
- decreased circulating serum albumin level / IMPC
- narrow eye opening / IMPC
- trunk curl / IMPC
- abnormal cornea morphology / IMPC
- abnormal eyelid aperture / IMPC
- abnormal rib morphology / IMPC
- abnormal iris morphology / IMPC
- excessive tearing / IMPC
- increased mean corpuscular hemoglobin / IMPC
- inflammation / IMPC
- abnormal eye pigmentation / IMPC
- increased thermal nociceptive threshold / IMPC
- abnormal eye size / IMPC
- increased bone mineral density / IMPC
- abnormal eye morphology / IMPC
- developmental and structural abnormality / IMPC
- increased circulating bilirubin level / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal pupil morphology / IMPC
MGI phenotypes (gene matching)
- abnormal leukocyte cell number / MGI
- increased monocyte cell number / MGI
- decreased leukocyte cell number / MGI
- decreased monocyte cell number / MGI
- increased granulocyte number / MGI
- abnormal thymus morphology / MGI
- decreased thymocyte number / MGI
- decreased body weight / MGI
- microphthalmia / MGI
- eyelids open at birth / MGI
- cataract / MGI
- small lens / MGI
- abnormal cornea morphology / MGI
- increased incidence of corneal inflammation / MGI
- corneal opacity / MGI
- abnormal pupil morphology / MGI
- abnormal iris morphology / MGI
- abnormal eye pigmentation / MGI
- abnormal retina morphology / MGI
- abnormal humoral immune response / MGI
- decreased IgG level / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal T cell physiology / MGI
- abnormal B cell physiology / MGI
- increased bone strength / MGI
- abnormal iridocorneal angle / MGI
- abnormal auditory brainstem response / MGI
- abnormal behavior / MGI
- decreased B-1 B cell number / MGI
- decreased lymphocyte cell number / MGI
- decreased B cell number / MGI
- decreased T cell number / MGI
- abnormal ciliary body morphology / MGI
- eyelids fail to open / MGI
- narrow eye opening / MGI
- abnormal corneal stroma morphology / MGI
- increased circulating bilirubin level / MGI
- growth/size/body region phenotype / MGI
- immune system phenotype / MGI
- corneal vascularization / MGI
- decreased circulating glucose level / MGI
- absent pinna reflex / MGI
- increased NK T cell number / MGI
- increased NK cell number / MGI
- increased CD4-positive, alpha beta T cell number / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- increased CD8-positive, alpha-beta T cell number / MGI
- decreased CD8-positive, alpha-beta T cell number / MGI
- increased single-positive T cell number / MGI
- decreased single-positive T cell number / MGI
- decreased follicular B cell number / MGI
- decreased mature B cell number / MGI
- decreased immature B cell number / MGI
- decreased IgG1 level / MGI
- decreased survivor rate / MGI
- eye opacity / MGI
- decreased transitional stage T1 B cell number / MGI
- increased bone mineral content / MGI
- symblepharon / MGI
- abnormal mature B cell number / MGI
- decreased sphingosine level / MGI
Literature references
- The role of sphingosine-1-phosphate transporter Spns2 in immune system function.;Nijnik Anastasia, Clare Simon, Hale Christine, Chen Jing, Raisen Claire, Mottram Lynda, Lucas Mark, Estabel Jeanne, Ryder Edward, Adissu Hibret, null null, Adams Niels C, Ramirez-Solis Ramiro, White Jacqueline K, Steel Karen P, Dougan Gordon, Hancock Robert E W, ;2012;Journal of immunology (Baltimore, Md. : 1950);189;102-11; 22664872
- Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss.;Chen Jing, Ingham Neil, Kelly John, Jadeja Shalini, Goulding David, Pass Johanna, Mahajan Vinit B, Tsang Stephen H, Nijnik Anastasia, Jackson Ian J, White Jacqueline K, Forge Andrew, Jagger Daniel, Steel Karen P, ;2014;PLoS genetics;10;e1004688; 25356849
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).